Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-01-04
2005-01-04
Fonda, Kathleen K. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S053000
Reexamination Certificate
active
06838448
ABSTRACT:
A solution for storing corneal tissue, especially at a temperature of 2 to 8° C., which comprises hyaluronic acid having an average molecular weight of less than 6,000,000 Da (preferably of from 50,000 to 250,000 Da).
REFERENCES:
patent: 0138572 (1985-04-01), None
patent: 0197718 (1986-10-01), None
patent: 0517972 (1992-12-01), None
patent: 6-107538 (1994-04-01), None
Translation of JP 6-107538, Apr. 1994, Shiseido Co Ltd, provided by Applicant with the reposne of Jul. 13, 2003.*
Fortschr. Ophthalmol., vol. 88, No. 2, Apr. 1991, pp. 113-117, M. Bohme, M. Hagenah & J. Draeger.
Database WPI, Section Ch., Week 9420, Derwent Publications Ltd., London, GB; AN 94-163841, JP6107538, Apr. 19, 1994.
LandOfFree
Corneal storage fluid comprised of hyaluronic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Corneal storage fluid comprised of hyaluronic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Corneal storage fluid comprised of hyaluronic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3415877